Who has invested in Idrx?

Andreessen Horowitz, Casdin Capital, Nextech Invest, Forge Life Science Partners are named among the investors backing Idrx.

Idrx Funding: $122M Raised, Series A (2022)

Idrx funding overview

Idrx is a Biotech company based in Boston, Massachusetts. Idrx has raised $122M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in August 2022. The round record for Idrx runs through 2022; nothing later has been disclosed. Investors on record include Andreessen Horowitz, Casdin Capital, Nextech Invest, Forge Life Science Partners. 4 distinct backers are named across the disclosed rounds.

Idrx at a glance

Total raised: $122M
Latest round: Series A
Latest round date: August 2022
Industry: Biotech
Headquarters: Boston, Massachusetts
Notable investors: Andreessen Horowitz, Casdin Capital, Nextech Invest, Forge Life Science Partners

Frequently asked about Idrx funding

How much has Idrx raised?: Idrx has raised $122M in total disclosed funding across the rounds on record.
Who has invested in Idrx?: Andreessen Horowitz, Casdin Capital, Nextech Invest, Forge Life Science Partners are named among the investors backing Idrx.
What was the latest Idrx funding round?: The most recent disclosed round is a Series A, announced in August 2022.
Where is Idrx based?: Idrx is based in Boston, Massachusetts.
What sector does Idrx operate in?: Idrx is tracked under Biotech from Boston, Massachusetts, with $122M in disclosed funding.
When did Idrx last raise?: The last disclosed Idrx round closed in August 2022 at Series A.

Every Idrx figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Boston at a similar stage.

Idrx Funding: $122M Raised, Series A (2022)

Idrx funding overview

Idrx at a glance

Frequently asked about Idrx funding

Companies related to Idrx (40)

Browse related funding lists (8)